Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Bvf Partners L P | 10% Owner | 2025-08-05 | 79 | $1.88 | $148.36Sell |
Bvf Partners L P | 10% Owner | 2025-08-05 | 66 | $1.88 | $123.95Sell |
Bvf Partners L P | 10% Owner | 2025-08-05 | 11 | $1.88 | $20.66Sell |
Growth N. V. Biotech | 10% Owner | 2024-11-01 | 2,000,000 | $1.53 | $3.06MSell |
Growth N. V. Biotech | 10% Owner | 2024-11-01 | 1,879,583 | $1.51 | $2.84MSell |
Growth N. V. Biotech | 10% Owner | 2024-11-01 | 2,000,000 | $1.53 | $3.06MSell |
Growth N. V. Biotech | 10% Owner | 2024-11-01 | 2,000,000 | $1.53 | $3.05MSell |
Peter Virsik | Chief Operating Officer | 2024-10-07 | 694 | $6.03 | $4.18kSell |
Peter Virsik | Chief Operating Officer | 2024-09-09 | 694 | $6.00 | $4.16kSell |
Peter Virsik | Chief Operating Officer | 2024-09-03 | 2,082 | $6.03 | $12.55kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Bvf Inc | 18.49% | 8,748,629 | $6.86M | Institution |
Tang Capital Management LLC | 9.09% | 4,300,000 | $3.37M | Institution |
Bml Capital Management LLC | 8.92% | 4,221,546 | $3.31M | Institution |
Morgan Stanley | 8.90% | 4,209,670 | $3.30M | Institution |
Clarus Lifesciences III LP | 7.55% | 3,573,053 | $2.80M | Insider |
Soleus Capital Management LP | 4.78% | 2,262,026 | $1.77M | Institution |
Opaleye Management Inc | 4.67% | 2,209,998 | $1.73M | Institution |
Pfizer Inc | 3.54% | 1,675,000 | $1.31M | Institution |
Franklin M. Berger | 1.66% | 784,404 | $614.97k | Insider |
Bank Of America Corp | 1.33% | 627,930 | $492.30k | Institution |